Inflammation and pain in pancreatic disorders: summary of the symposium sponsored by the American Pancreatic Association and the National Pancreas Foundation (Chicago, November 4-5, 2005).
Saluja
Ashok
A
University of Massachusetts Medical School, Department of Surgery, Worcester, MA 01605, USA. Ashok.Saluja@umassmed.edu
Dudeja
Vikas
V
Phillips
Phoebe
P
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D018925:Chemokines / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D010146:Pain / Q000276:immunology / Q000378:metabolism; D059408:Pain Management; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D010195:Pancreatitis / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D015398:Signal Transduction; D050916:TRPV Cation Channels / Q000378:metabolism; D051197:Toll-Like Receptor 4 / Q000378:metabolism
D000970:Antineoplastic Agents; D018925:Chemokines; D016207:Cytokines; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D051197:Toll-Like Receptor 4